|
We asked 50 pharma leaders,  how do you think the reputation of the pharma industry has changed in recent years?
| Improved |
3% |
Stayed the same |
33% |
| Declined |
64% |
 |
|
|
|
|
|
|
|
19 March, 2013
|
| In this Issue |
Last Chance to Vote for 2013's Emerging Pharma Leaders
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input! Tell us who you think should receive Pharmaceutical Executive's Emerging Pharma Leadership Award. Fill out a nomination today ...Read more |
India Prepares for BioPharma Push
New guidelines on good distribution practices for biologics will have a significant impact on the Indian pharma sector — for good or ill. Jane Wan reports ... Read more |
Late Phase Market Outlook 2013
Market data and analysis on Phase IV, Phase IIIb, HEOR, registries, and comparative effectiveness studies from ISR’s report ‘Late Phase Market Overview and Outlook’ ... Read more |
Emerging Markets and "Reverse Innovation"
Emerging country markets are widely viewed as Big Pharma’s ace in the hole to replace declining rates of innovation in the US and Europe, with numerous studies claiming the BRICK nations (the ‘K’ is from South Korea) are at the center of a revolutionary global shift in the source points for new ideas — what observers call the phenomenon of “reverse innovation.” ... Read more
|
|
|
|
